Outliving Cancer | Podcast en RSS.com

Outliving Cancer

Outliving Cancer

por Dr. Robert Nagourney

Medicina Ciencias Naturales Documentales

Temporada 1

A Discussion of Fibrolamellar Cancer

Tom Stockwell, whose son passed away from a rare cancer shortly after being diagnosed at age 18, has focused on helping others find personalized treatment and ultimately, hopefully, a cure. On today’s episode, Dr. Nagourney talks with Tom.

More on the Topic of Breast Cancer

Dr. Nagourney continues his discussion on the details of a disease that is so important to millions of Americans as he interviews Maria Lewis, who overcame advanced cancer several years ago by using functional profiling.

An Introduction to the Topic of Breast Cancer

Dr. Nagourney discusses the details of a disease that is so important to millions of Americans as he interviews Maria Lewis, who overcame advanced cancer several years ago by using functional profiling.

Remarkable Examples of Results for Patients of Advanced Years

Dr. Nagourney highlights several remarkable examples of results for patients of advanced years in this episode of Outliving Cancer.

The Influence of Age on Cancer Therapy

The influence of age on cancer therapy. Dr. Nagourney examines the process of aging and its impact on cancer care.

Human Tumor Biology is Evolutionary

Dr. Nagourney discusses how human tumor biology is evolutionary. If we consider how cancers adapt to micro-environmental stressors, many of which we call therapies, we see the process of evolution accelerated as cancer cells divide. By condensing evolutionary adaptation, cancers can outdo our best therapies.

The Distinction Between Gene Tests and Functional Tests

Dr. Nagourney examines the important distinction between gene tests and functional tests. It is critically important that all patients understand this fundamental distinction if they are to use functional profiling to gain the upper hand in their cancer management.

Drugs Don’t Know for What They Were Invented

Dr. Nagourney discusses how drugs gain FDA approval and go on to clinical application but fail to realize their full potential as rigid guidelines undermine the intelligent use of active treatments and combinations.

An Introduction to Outliving Cancer

Cancer patients today confront a dizzying array of treatment options but current “protocol-driven” therapies have had little impact on survival. Patients need actionable information and Dr. Nagourney provides just that.